Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis

NCT06184659 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

5800

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Septic Shock

Interventions

DRUG: Meropenem
DRUG: Piperacillin/Tazobactam

Sponsor

Scandinavian Critical Care Trials Group